NOVARTIS FARMA - PRODUTOS FARMACEUTICOS, S.A. secures contract for Direct Adjustment No 192 2026 Medicine Inclisiran 189 Mg Ml Sol Inj Ser 15 Ml Sc Under The Framework Agreement Spms 2024 961

Portugal, April 14 -- Portugal based NOVARTIS FARMA - PRODUTOS FARMACEUTICOS, S.A. has secured contract from Unidade Local De Saude De Santo Antonio, E. P. E. for Direct Adjustment No 192 2026 Medicine Inclisiran 189 Mg Ml Sol Inj Ser 15 Ml Sc Under The Framework Agreement Spms 2024 961. The value of the contract is worth 12235440 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....